The Centre of Regulatory Excellence (CoRE) was established with support from Singapore’s Economic Development Board, Health Sciences Authority and Ministry of Health as the first Asian Centre dedicated to addressing the capacity development and policy innovation needs of national health product and health systems regulators, the biomedical industry, pharmaceutical and medical device companies, and biomedical researchers.
Formally inaugurated in November 2014, CoRE was established at the Duke-NUS Medical School in Singapore to support the strengthening of health product regulatory systems in the Asia-Pacific region, with a special focus on South-East Asia. CoRE provides a neutral platform for stakeholder interaction, learning and discussion in the academic setting of Duke-NUS Medical School. Aligned with Duke-NUS’ vision, “Transforming Medicine, Improving lives”, CoRE focuses on being a neutral scientific regulatory entity, “Enabling regulatory excellence, Improving lives”.
Ultimately, CoRE aims to create an environment in which new healthcare products can be developed, commercialised and delivered to populations across South-East Asia and Asia Pacific with greater efficacy, quality and safety, and advance policy innovation for health products and health systems regulation to respond to the many new biomedical and therapeutic developments.